Holen Sie sich die Stockscreener-App
1.41
0.00%
0.00
Exicure Inc Aktie (XCUR) Neueste Nachrichten
Total common shares outstanding of Exicure, Inc. – HAM:2H0 - TradingView
Return on assets % of Exicure, Inc. – HAM:2H0 - TradingView
Exicure Stock Price Forecast. Should You Buy XCUR? - StockInvest.us
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - barchart.com
Exicure (XCUR) Watch: Falls 11.54% to $1.15 in the Latest Session; Range View: Support at $1.09 and Resistance at $1.21 Frame the RangeRounding Top - vinanet.vn
Exicure (XCUR) Price: Declines 11.54% to $1.15 in the Latest Reading; Range View: Support at $1.09 and Resistance at $1.21 Frame the Range for the Current SessionEqual Weight ETF - vinanet.vn
Exicure (XCUR) Quarterly Figures: EPS Comes in Below Forecast for This Review; Share Response: The Stock Ends Down 10.34% for the Current SessionGuidance Update - vinanet.vn
EXICURE, INC. Q2 2026: Revenue $0 Net income $(1.12M) — 10-Q Summary - TradingView
Exicure Deadline Alert - TMX Newsfile
Exicure Update - TMX Newsfile
Exicure Inc (XCUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Exicure Inc (XCUR) Stock News Today - TradingKey
XCUR Q2 2022 Earnings: Wider-than-Expected Loss Weighs on SharesCFO Commentary Report - vinanet.vn
Trading Systems Reacting to (XCUR) Volatility - Stock Traders Daily
Exicure Shareholder Alert - TMX Newsfile
XCUR Looks 231.6% Overvalued on GF Value™ - GuruFocus
Exicure to issue shares to settle $1M clinical milestone payment - Investing.com
Exicure to issue shares to settle $1M clinical milestone payment By Investing.com - Investing.com Nigeria
Exicure Announces Planned Issuance of Common Stock to Settle $1.0 Million Milestone Payment to GPCR Therapeutics - Quiver Quantitative
XCUR Q2 2022 Earnings: EPS Misses by 35.6% as No Revenue ReportedDividend Cut Risk - vinanet.vn
Exicure Inc. (XCUR) Rises 4.46% to $1.64 as Shares Approach Key Resistance LevelETF Creation Redemption - vinanet.vn
Exicure Inc (XCUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Exicure Inc (XCUR) Cash Flow - TradingKey
Exicure Inc (XCUR) Institutional Confidence - TradingKey
Exicure Inc (XCUR) Balance Sheet - TradingKey
Exicure Inc (XCUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Exicure Inc (XCUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Exicure Inc (XCUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XCUR|Exicure Inc|Price:1.330|Chg%:-0.180 - TradingKey
XCUR|Exicure Inc|Price:1.750|Chg%:-0.010 - TradingKey
XCUR|Exicure Inc|Price:1.760|Chg%:+0.050 - TradingKey
XCUR Q2 2022 Earnings: EPS Misses Estimates Amid Ongoing Operational ChallengesPost-Earnings Reaction - vinanet.vn
Exicure Inc (XCUR) Income Statement - TradingKey
Exicure, Inc. Revenue Breakdown – NASDAQ:XCUR - TradingView
Exicure Inc (XCUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
XCUR stock trades on limited evidence as Exicure waits for filings - Ad-hoc-news.de
XCUR|Exicure Inc|Price:1.700|Chg%:-0.010 - TradingKey
XCUR Q2 2022 Earnings: EPS Misses Estimates, Stock Declines as Pre-Revenue Biotech Faces ChallengesOperating Margin Analysis - vinanet.vn
Form 4 Exicure Inc For: 17 July By Investing.com - Investing.com Nigeria
Exicure Inc. (XCUR) Q2 2022 Earnings: EPS Misses Estimates Significantly, Stock Rises 3.7%Earnings Decline Risk - vinanet.vn
Form 13D/A EXICURE For: 17 July By Investing.com - Investing.com Nigeria
Exicure, Inc. (XCUR) holder Exicure HiTron regains 623,275 returned shares - Stock Titan
Exicure HiTron boosts Exicure (XCUR) holding to 2.22M shares, 34.87% - Stock Titan
XCUR Q2 2022 Earnings: Significant EPS Miss Highlights Ongoing Challenges for ExicureCost Structure Review - vinanet.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Exicure (XCUR) Q2 2022 Earnings: Wider-Than-Expected Loss as Revenue Remains AbsentHigh Estimate Range - vinanet.vn
Trending Stocks Today | Exicure Shoots up 31.39% Post-Market - Moomoo
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Exicure Q2 2022 Earnings: Deep EPS Miss Overshadows Modest Stock ReactionEarnings Surprise Stocks - vinanet.vn
Exicure Inc. (XCUR) Q2 2022 Earnings: Significant Earnings Miss and Negative Stock ReactionEarnings Sentiment Score - dars.gov.et
How Exicure Inc. (XCUR) Affects Rotational Strategy Timing - Stock Traders Daily
Stock Market News: Ethan Allen Interiors down by 90.10% while Exicure gains 99.48% during mid day trading - Business Upturn
Exicure Inc. (XCUR) Slips 7.89%: Key Support Levels Under ScrutinyDealer Delta - dars.gov.et
XCUR Q2 2022 Earnings: Wider-than-Expected Loss Drives Double-Digit DeclineFree Cash Flow Trends - dars.gov.et
Exicure stock holds its line. Company context stays front and center. - Ad-hoc-news.de
Debt to assets ratio of Exicure, Inc. – DUS:2H0 - TradingView
Non-controlling/minority interest of Exicure, Inc. – DUS:2H0 - TradingView
Enterprise value to EBITDA forward of Exicure, Inc. – NASDAQ:XCUR - TradingView
Exicure stock leans on its cash position. Nasdaq listing keeps it visible. - Ad-hoc-news.de
(XCUR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Exicure refreshes board with new independent directors - The Globe and Mail
New directors join Exicure (NASDAQ: XCUR) board as compensation committee forms - Stock Titan
Exicure announces board changes, adds two new directors By Investing.com - Investing.com Nigeria
Exicure announces board changes, adds two new directors - Investing.com
Press Release: Exicure Announces Board and Committee Changes - Moomoo
0.28%
3.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):